OTC · Biotechnology

Deltagen Inc. (DGEN) Stock

$0.00 OTC: DGEN Healthcare

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry.

Valuation

MetricValue
Price$0.00
Market Cap$3859
P/E Ratio0.04
P/B Ratio0.00
P/S Ratio3.57
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-2.72%
ROA-1.58%
ROCE4.42%
Gross Margin—
Operating Margin29.28%
Net Margin-5.97%
Debt/Equity0.01
Current Ratio1.45

Annual Financials (USD)

Metric20092010201220132014
Revenue$1.0M$2.0M$1.0M$1.0M$0
Operating Profit$-1.0M$-1.0M$0$0$0
Net Profit$-1.0M$-1.0M$-1.0M$-4.0M$0
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin-51.8%-34.9%-5.0%11.0%29.3%

Balance Sheet (USD)

Metric20092010201220132014
Total Assets$8.0M$7.0M$6.0M$2.0M$2.0M
Total Liabilities$0$0$0$0$0
Cash$6.0M$4.0M$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20092010201220132014
Operating Cash Flow$-1.0M$-2.0M$-1.0M$0—
Investing Cash Flow$0$0$0$0—
Financing Cash Flow$0$-1.0M$-1.0M$0—
Net Cash Flow$0$0$0$0—
Free Cash Flow$-1.0M$-2.0M$-1.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.37
FCF Yield0.00%
Quick Ratio2.30
Interest Coverage—
Return 1Y0.00%
Return 3Y0.00%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CVHIFVentura Cannabis & Wellness Corporation $0.00 — 0.00 $3704 0.00%
CYPSCyclo3pss Corporation $0.00 — — $4054 0.00%
NMRDNemaura Medical Inc. $0.00 — 0.00 $4035 0.00%
NMXSNet Medical Xpress Solutions, Inc. $0.00 — -0.01 $26367 0.00%
QMDTQuick-Med Technologies, Inc. $0.00 — -0.04 $29877 0.00%

About Deltagen Inc.

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.

Deltagen Inc. (DGEN) stock trades at $0.00 with a market capitalization of $3859. The stock is valued at a price-to-earnings (P/E) ratio of 0.04, price-to-book of 0.00, price-to-sales of 3.57.

On profitability, Deltagen Inc. generates a return on equity (ROE) of -2.72% (negative, reflecting a net loss), return on capital employed of 4.42%, an operating margin of 29.28%, a net profit margin of -5.97%.

Official website: www.d-gen.co.il

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.